1. Home
  2. Clinical Topics
  3. Survey reveals 40% of patients with MS stop taking medications because of cost
Clinical TopicsDrugs and DevicesNeurologyNews

Survey reveals 40% of patients with MS stop taking medications because of cost

Share
By: Lydia L. Kim, Digital Content Editor

A new survey conducted by the National MS Society (NMSS) reveals that 40% of respondents “altered or stopped taking their [MS-associated] medication” due to the medication(s) high costs.

NMSS also highlights that in 2019, the median price for disease modifying therapy for MS was $88,000, and that in 2020, these prices have already increased. The impact this type of pricing has on individuals living with MS is immense, and this new survey highlights one of the most heartbreaking results.

Please read more about the survey here.

Source:
https://www.nationalmssociety.org/About-the-Society/News/New-Survey-Shows-40-of-People-with-MS-Alter-or-Sto

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts